A Phase I Trial to Evaluate Safety and Efficacy of Topically Applied GSK2981278 Ointment in a Psoriasis Plaque Test
Phase of Trial: Phase I
Latest Information Update: 20 May 2017
At a glance
- Drugs GSK 2981278 (Primary) ; Betamethasone valerate
- Indications Plaque psoriasis
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- Sponsors GlaxoSmithKline
- 07 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 18 Dec 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 19 Sep 2015 New trial record